Clinical trial
Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
NCT04343742 is registered in ClinicalTrials.gov with Genesis Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
- Lead sponsor
- Genesis Foundation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2020
- Completion date
- June 1, 2020
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.